| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 3.359 | 17.843 | 19.582 | 19.531 | 4.764 | 0 | 27.870 | 26.648 |
| Total Income - EUR | - | - | 3.359 | 17.843 | 19.582 | 19.531 | 5.361 | 599 | 28.467 | 26.812 |
| Total Expenses - EUR | - | - | 71 | 335 | 1.251 | 855 | 2.375 | 2.404 | 3.659 | 12.183 |
| Gross Profit/Loss - EUR | - | - | 3.288 | 17.508 | 18.331 | 18.676 | 2.986 | -1.804 | 24.808 | 14.629 |
| Net Profit/Loss - EUR | - | - | 3.187 | 16.973 | 17.743 | 18.134 | 2.843 | -1.804 | 21.315 | 14.363 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Occipitrix S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 40 | 0 | 0 | 0 | 3.565 | 4.107 | 2.402 | 1.082 |
| Current Assets | - | - | 3.511 | 20.510 | 23.003 | 20.499 | 14.585 | 11.476 | 36.467 | 46.631 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 1.680 | 0 | 0 | 820 | 0 | 24 | 580 | 136 |
| Cash | - | - | 1.831 | 20.510 | 23.003 | 19.679 | 14.585 | 11.452 | 35.886 | 46.495 |
| Shareholders Funds | - | - | 3.231 | 20.145 | 22.746 | 18.175 | 16.572 | 14.819 | 36.089 | 46.631 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 320 | 366 | 256 | 323 | 218 | 0 | 2.615 | 1.082 |
| Income in Advance | - | - | 0 | 0 | 0 | 2.001 | 1.359 | 764 | 165 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5912 - 5912" | |||||||||
| CAEN Financial Year |
5912
|
|||||||||
Comments - Occipitrix S.r.l.